Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Initial study finds promise and limitations in using virtual reality (VR) to treat ADHD

___

Giv­en the lim­i­ta­tions of exist­ing evi­dence-based ADHD treat­ments, i.e., stim­u­lant med­ica­tion and behav­ior ther­a­py — research on nov­el inter­ven­tion approach­es con­tin­ues to be impor­tant.

Cog­ni­tive train­ing is one such approach that has been sug­gest­ed as a poten­tial adjunct or even replace­ment for med­ica­tion treat­ment. While cog­ni­tive train­ing takes dif­fer­ent forms, e.g., com­put­er­ized atten­tion train­ing, work­ing mem­o­ry train­ing, the basic idea is that by repeat­ed­ly prac­tic­ing cog­ni­tive tasks relat­ed to atten­tion, one’s abil­i­ty to focus and attend will improve. In oth­er words, Read the rest of this entry »

Update: Large study finds that consistent use of ADHD medication may stunt growth by 2 inches (5 centimeters)

___

Time for Sharp­Brains’ eNewslet­ter, bring­ing you lat­est news around med­ica­tion, brain train­ing, sup­ple­ments, mind-wan­der­ing, dig­i­tal ther­a­peu­tics, wear­ables, and more — and also a few quick brain teasers to wrap-up.

New research:

New thinking:

New tools:

 

Final­ly, we have a cou­ple of fun, quick brain teasers for you, and also a selec­tion of arti­cles to cel­e­brate Brain Aware­ness Week 2018.

Have a great spring,

The Sharp­Brains Team

Consistent use of ADHD medication may stunt growth by 2 inches, large study finds

___

The Mul­ti­modal Treat­ment Study of ADHD (MTA Study) is the largest ADHD treat­ment study ever con­duct­ed — near­ly 600 7–9-year-old chil­dren with ADHD were ran­dom­ly assigned to one of four inter­ven­tions:

1) Care­ful­ly mon­i­tored med­ica­tion treat­ment;

2) Inten­sive behav­ior ther­a­py;

3) Med­ica­tion Treat­ment com­bined with Behav­ior Ther­a­py; or

4) Com­mu­ni­ty Care (par­ents obtained what­ev­er treat­ment they desired).

After 14 months, results indi­cat­ed that Read the rest of this entry »

Pending FDA review and approval, research findings pave way for Akili’s EVO to become first brain training platform prescribed for ADHD

Akili Achieves Pri­ma­ry Effi­ca­cy End­point in ADHD Tri­al (MD mag­a­zine):

Boston-based Akili Inter­ac­tive has announced top-line results from the STARS-ADHD piv­otal study of its inves­ti­ga­tion­al dig­i­tal ther­a­peu­tic med­i­cine AKL-T01, in treat­ment of pedi­atric atten­tion-deficit/hy­per­ac­tiv­i­ty dis­or­der (ADHD)…The dig­i­tal med­i­cine, AKL-T01, is a video game for patients to play on tablet devices. It uses the same sto­ry­telling and reward mech­a­nisms as stan­dard videogames; how­ev­er, it fea­tures mech­a­nisms to act on neur­al sys­tems and algo­rithms that dial the lev­el of stim­u­lus up or down, meet­ing the needs of the patient. Read the rest of this entry »

Survey: Parents view Exercise as more effective than Prescription Medications to treat children with ADHD

Con­sid­er how research sup­port for ADHD treat­ments are typ­i­cal­ly estab­lished. The ‘gold-stan­dard’ approach would be a ran­dom­ized-con­trolled tri­al in which chil­dren with ADHD are ran­dom­ly assigned to the treat­ment or con­trol group. The treat­ment, what­ev­er it hap­pens to be, would be care­ful­ly imple­ment­ed in a research-based pro­to­col. If pos­si­ble Read the rest of this entry »

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters and more, SharpBrains is an independent market research firm tracking health and performance applications of brain science.

Follow us and Engage via…

twitter_logo_header
RSS Feed

Search for anything brain-related in our article archives

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.